Cipla Ltd.
FDA inspection history in Bengaluru, India, 2020 to 2025
- 2
- Form 483s
Every document, by year
- Form 483
2020: one Form 483; 2025: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2020One Form 483, at Bengaluru, India.
- 2020The longest 483 on file: 4 observations over 1 pages at Bengaluru, India.
- 2025One Form 483, at Bengaluru, India.
Cited most
Across all Cipla observations on file
- 21 CFR 211.110Sampling and testing of in-process materials and drug products2
- 21 CFR 211.188Batch production and control records1
- 21 CFR 211.192Production record review1
The complete Cipla file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Bengaluru, India
Two Form 483s · 2020 to 2025 · 5 observations
Latest: Form 483, May 30, 2025 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2025-05-30 | 483 Form 483 | Bengaluru, India | 1 | $99 |
| 2020-01-24 | 483 Form 483 | Bengaluru, India | 4 | $99 |
Investigators on these documents
FEI number 3005857289 · most recent document May 30, 2025
About Cipla Ltd.
How many FDA Form 483s has Cipla Ltd. received?
FDA Intel has 2 Form 483s on file for Cipla Ltd.; the most recent is dated May 30, 2025.
When was Cipla Ltd. last inspected by FDA?
The most recent FDA inspection document on file for Cipla Ltd. is a Form 483 dated May 30, 2025, for the site in Bengaluru, India.
What did FDA cite at Cipla Ltd.?
The regulations cited most in the observations on file for Cipla Ltd. are 21 CFR 211.110 (Sampling and testing of in-process materials and drug products), 2 times; 21 CFR 211.188 (Batch production and control records), 1 time; 21 CFR 211.192 (Production record review), 1 time.